|1.||Grinstein, Saúl: 2 articles (06/2007 - 04/2004)|
|2.||Bertot, Gustavo M: 2 articles (06/2007 - 04/2004)|
|3.||Restelli, Marcela A: 1 article (06/2007)|
|4.||Valvano, Miguel A: 1 article (06/2007)|
|5.||Galanternik, Laura: 1 article (06/2007)|
|6.||Aranibar Urey, Rene C: 1 article (06/2007)|
|7.||Becker, Pablo D: 1 article (04/2004)|
|8.||Guzmán, Carlos A: 1 article (04/2004)|
|9.||Vacek, A: 1 article (01/2001)|
|10.||Thurnvaldová, J: 1 article (01/2001)|
01/01/2001 - "1-Adamantylamide-L-alanyl-D-isoglutamine (adamantylamide dipeptide (AdDP)) belongs to a group of desmuramyl muramyl peptide derivatives which are able to protect an organism from some viral infections. "
04/01/2004 - "Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae."
01/01/1996 - "Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni."
06/01/2007 - "Nasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. "
04/01/1990 - "Effect of immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection."
|3.||Human Influenza (Influenza)
|5.||Delayed Hypersensitivity (Hypersensitivity, Type IV)
11/01/1984 - "The adjuvant effect of a novel synthetic compound adamantylamide dipeptide (AdDP) was tested in a model of delayed hypersensitivity to ovalbumin in guinea pigs, and of immunostimulatory activity in the experiments with 3H thymidine where DNA biosynthesis was measured in several immunocompetent organs after administration of adamantylamide dipeptide. "
|2.||Membrane Proteins (Integral Membrane Proteins)
|5.||DNA (Deoxyribonucleic Acid)